Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates

Didier Ghisalberti1, Abdallah Mahamoud, Jacqueline Chevalier

  • 1EA2197, IFR48, Université de la Méditerranée, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France.

Insights

New chloroquinoline derivatives can overcome bacterial multidrug resistance by inhibiting efflux pumps. These compounds make resistant bacteria more susceptible to antibiotics, offering potential new treatments for infections.

Area of Science:

  • Microbiology
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Bacterial efflux pumps actively expel toxic compounds, contributing significantly to multidrug resistance.
  • Targeting these efflux mechanisms is crucial for combating multidrug-resistant bacterial infections.

Purpose of the Study:

  • To investigate the potential of novel chloroquinoline derivatives as inhibitors of bacterial efflux pumps.
  • To evaluate the efficacy of these compounds in restoring antibiotic susceptibility in resistant bacterial strains.

Main Methods:

  • Synthesis and characterization of new chloroquinoline derivatives.
  • Testing the effect of derivatives on the susceptibility of multidrug-resistant Enterobacter aerogenes isolates to various antibiotics.
  • Measuring intracellular antibiotic concentrations to confirm efflux pump inhibition.

Main Results:

  • Several chloroquinoline derivatives demonstrated the ability to re-sensitize multidrug-resistant Enterobacter aerogenes to antibiotics.
  • Some compounds were shown to increase intracellular chloramphenicol levels, indicating efflux pump inhibition.
  • Specific molecules were identified as inhibitors of the AcrAB-TolC efflux pump, a key factor in E. aerogenes resistance.

Conclusions:

  • Novel chloroquinoline derivatives show promise as agents to combat bacterial multidrug resistance.
  • These compounds can restore antibiotic efficacy by inhibiting critical bacterial efflux pumps like AcrAB-TolC.
  • Further development of these chloroquinolines could lead to new therapeutic strategies against resistant bacterial infections.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...